Skip to navigation Skip to content

News

Share

Researchers Report Success Reducing MS-like Disease in Mice

May 22, 2015

Researchers from the University of Montreal report that a molecule called "MCAM" helps immune cells to enter and attack the brain and spinal cord in mice with an MS-like disease. They found that blocking this molecule reduced disease activity in relapsing and progressive models of the disease. More study is needed to determine whether this blocking agent, now under development for psoriasis, has potential benefits for people with MS.

Read more on Medical News Today.

Read more about research in progressive MS.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share

© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.